Market Definition
Medication-assisted treatment (MAT) involves using medications, combined with counselling and behavioural therapies, to provide a complete patient approach for treating substance use disorders. For opioid overdose prevention medication, naloxone is used to prevent opioid overdose by reversing the toxic effects of the overdose. According to the World Health Organization (WHO) and Substance Abuse and Mental Health Services Administration (SAMHSA) naloxone is one of many medications considered essential to a functioning health care system. North America Medication-Assisted Treatment
North America Medication-Assisted Treatment (MAT) Market Scope
The medication-assisted (MAT) treatment market is segmented on the basis of eight segments: type, products, drug type, and dosage form, route of administration, population type, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Medication
- Therapy
On the basis of type, the North America medication-assisted treatment (MAT) market is segmented into medication and therapy.
Products
- Buprenorphine and Naloxone
- Naltrexone
- Buprenorphine
- Methadone
- Naloxone
- Disulfiram
- Acamprosate
On the basis of products, the North America medication-assisted treatment (MAT) market is segmented into buprenorphine and naloxone, naltrexone, buprenorphine, methadone, naloxone, disulfiram and acamprosate.
Drug Type
- Generics
- Branded
On the basis of drug type, the North America medication-assisted treatment (MAT) market is segmented into generics and branded.
Dosage Form
- Immediate Release
- Extended Release
On the basis of dosage form, the North America medication-assisted treatment (MAT) market is segmented into immediate release and extended release.
Route of Administration
- Oral
- Parenteral
- Others
On the basis of route of administration, the North America medication-assisted treatment (MAT) market is segmented into oral, parenteral and others.
Population Type
- Adults
- Teenage
On the basis of population type, the North America medication-assisted treatment (MAT) market is segmented into adults and teenage.
End User
- Rehabilitation Clinics
- Hospitals
- Specialty Centers
- Homecare
- Others
Get The Full Access of Sample Report:- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-medication-assisted-treatment-mat-market
Medication-Assisted (MAT) Treatment Market Regional Analysis/Insights
The North America medication-assisted treatment (MAT) market is analysed and market size insights and trends are provided by regions, product type, type, application, workflow, end user and distribution channel as referenced above.
The countries covered in the medication-assisted (MAT) treatment market report are U.S., Canada and Mexico.
The U.S. is expected to dominate the market due to a rise in opioid dependency on medication, healthcare expenditure, and pharmaceutical companies.
Major TOC of The Report
Chapter One:- Introduction
Chapter Two_ Segmentation
Chapter Three:- Market Definition
Market Four:- Market Scope
Get TOC Details:- https://www.databridgemarketresearch.com/toc/?dbmr=north-america-medication-assisted-treatment-mat-market
Browse Related Reports: -
Global Medication-Assisted Treatment (MAT) Market
Europe Medication-Assisted Treatment (MAT) Market
Asia-Pacific Medication-Assisted Treatment (MAT) Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
